Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value
$327.52M
Total Bought
$30.42M
Total Sold
$0
Net Transaction
+$30.42M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ZENAS BIOPHARMA INC(ZBIO)3,761,3593,761,359036,44883,50225.49%+47,055
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)02,626,946+2,626,946030,4209.29%+30,420
SIONNA THERAPEUTICS INC(SION)2,478,0302,478,030042,99472,87922.25%+29,885
UPSTREAM BIO INC(UPB)2,459,7032,459,703027,00846,26714.13%+19,259
IMMUNOME INC(IMNM)4,768,5834,768,583044,34855,84017.05%+11,492
COMPASS THERAPEUTICS INC(CMPX)7,788,1507,788,150020,24927,2598.32%+7,009
CAMP4 THERAPEUTICS CORP(CAMP)3,785,8023,785,80205,48911,3573.47%+5,868
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q3 2025 | TickerTrail